Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Corrigendum: Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer.

Chen Q, Boire A, Jin X, Valiente M, Emrah Er E, Lopez-Soto A, Jacob LS, Patwa R, Shah H, Xu K, Cross JR, Massagué J.

Nature. 2017 Apr 6;544(7648):124. doi: 10.1038/nature21730. Epub 2017 Mar 29. No abstract available.

PMID:
28355178
2.

Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.

Boire A, Zou Y, Shieh J, Macalinao DG, Pentsova E, Massagué J.

Cell. 2017 Mar 9;168(6):1101-1113.e13. doi: 10.1016/j.cell.2017.02.025.

PMID:
28283064
3.

Understanding the molecular mechanisms driving metastasis.

Massagué J, Batlle E, Gomis RR.

Mol Oncol. 2017 Jan;11(1):3-4. doi: 10.1002/1878-0261.12024. No abstract available.

4.

Tissue factor-specific ultra-bright SERRS nanostars for Raman detection of pulmonary micrometastases.

Nayak TR, Andreou C, Oseledchyk A, Marcus WD, Wong HC, Massagué J, Kircher MF.

Nanoscale. 2017 Jan 19;9(3):1110-1119. doi: 10.1039/c6nr08217c.

PMID:
27991632
5.

Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer.

Chen Q, Boire A, Jin X, Valiente M, Er EE, Lopez-Soto A, Jacob LS, Patwa R, Shah H, Xu K, Cross JR, Massagué J.

Nature. 2016 May 26;533(7604):493-8. doi: 10.1038/nature18268. Epub 2016 May 18.

6.

Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.

Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, de Stanchina E, Massagué J.

Cell. 2016 Mar 24;165(1):45-60. doi: 10.1016/j.cell.2016.02.025.

7.

Arresting supporters: targeting neutrophils in metastasis.

Acharyya S, Massague J.

Cell Res. 2016 Mar;26(3):273-4. doi: 10.1038/cr.2016.17. Epub 2016 Jan 29.

8.

Metastatic colonization by circulating tumour cells.

Massagué J, Obenauf AC.

Nature. 2016 Jan 21;529(7586):298-306. doi: 10.1038/nature17038. Review.

9.

Surviving at a distance: organ specific metastasis.

Obenauf AC, Massagué J.

Trends Cancer. 2015 Sep 1;1(1):76-91.

10.

Metastatic Competence Can Emerge with Selection of Preexisting Oncogenic Alleles without a Need of New Mutations.

Jacob LS, Vanharanta S, Obenauf AC, Pirun M, Viale A, Socci ND, Massagué J.

Cancer Res. 2015 Sep 15;75(18):3713-9. doi: 10.1158/0008-5472.CAN-15-0562. Epub 2015 Jul 24.

11.

Therapy-induced tumour secretomes promote resistance and tumour progression.

Obenauf AC, Zou Y, Ji AL, Vanharanta S, Shu W, Shi H, Kong X, Bosenberg MC, Wiesner T, Rosen N, Lo RS, Massagué J.

Nature. 2015 Apr 16;520(7547):368-72. doi: 10.1038/nature14336. Epub 2015 Mar 25.

12.

Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S.

Sevenich L, Bowman RL, Mason SD, Quail DF, Rapaport F, Elie BT, Brogi E, Brastianos PK, Hahn WC, Holsinger LJ, Massagué J, Leslie CS, Joyce JA.

Nat Cell Biol. 2014 Sep;16(9):876-88. doi: 10.1038/ncb3011. Epub 2014 Aug 3.

13.

Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer.

Vanharanta S, Marney CB, Shu W, Valiente M, Zou Y, Mele A, Darnell RB, Massagué J.

Elife. 2014 Jun 4;3. doi: 10.7554/eLife.02734.

14.

RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation.

Morales M, Arenas EJ, Urosevic J, Guiu M, Fernández E, Planet E, Fenwick RB, Fernández-Ruiz S, Salvatella X, Reverter D, Carracedo A, Massagué J, Gomis RR.

EMBO Mol Med. 2014 Jul;6(7):865-81. doi: 10.15252/emmm.201303675.

15.

Metastatic stem cells: sources, niches, and vital pathways.

Oskarsson T, Batlle E, Massagué J.

Cell Stem Cell. 2014 Mar 6;14(3):306-21. doi: 10.1016/j.stem.2014.02.002. Review.

16.

Serpins promote cancer cell survival and vascular co-option in brain metastasis.

Valiente M, Obenauf AC, Jin X, Chen Q, Zhang XH, Lee DJ, Chaft JE, Kris MG, Huse JT, Brogi E, Massagué J.

Cell. 2014 Feb 27;156(5):1002-16. doi: 10.1016/j.cell.2014.01.040.

17.

TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition.

Stankic M, Pavlovic S, Chin Y, Brogi E, Padua D, Norton L, Massagué J, Benezra R.

Cell Rep. 2013 Dec 12;5(5):1228-42. doi: 10.1016/j.celrep.2013.11.014.

18.

Origins of metastatic traits.

Vanharanta S, Massagué J.

Cancer Cell. 2013 Oct 14;24(4):410-21. doi: 10.1016/j.ccr.2013.09.007. Review.

19.

Hypoxia signaling--license to metastasize.

Vanharanta S, Massagué J.

Cancer Discov. 2013 Oct;3(10):1103-4. doi: 10.1158/2159-8290.CD-13-0481.

20.

Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

Zhang XH, Jin X, Malladi S, Zou Y, Wen YH, Brogi E, Smid M, Foekens JA, Massagué J.

Cell. 2013 Aug 29;154(5):1060-73. doi: 10.1016/j.cell.2013.07.036.

Supplemental Content

Loading ...
Support Center